A phase III randomised trial comparing sequential to standard chemotherapy in advanced non-small cell lung cancer (NSCLC).

Sculier, J.; Lafitte, J.; Lecomte, J.; Alexopoulos, C.G.; Van Cutsem, O.; Giner, V.; Efremidis, A.; Scherpereel, A.; Paesmans, M.; Berghmans, T.

A phase III randomised trial comparing sequential to standard chemotherapy in advanced non-small cell lung cancer (NSCLC).

Sculier, J.

;

Lafitte, J.

;

Lecomte, J.

;

Alexopoulos, C.G.

;

Berghmans, T.

;et.al.

(2006) 42nd Annual Meeting of the American-Society-of-Clinical-Oncology — Location: Atlanta(Ga) (2.June.2006)

Files

No attached file found for this publication.

Details

Authors

Sculier, J.
Author
Lafitte, J.
Author
Lecomte, J.
Author
Alexopoulos, C.G.
Author
Berghmans, T.
Author

Affiliations

UCLouvainAutre

Citations

APA
Chicago
FWB

Sculier, J., Lafitte, J., Lecomte, J., Alexopoulos, C. G., Van Cutsem, O., Giner, V., Efremidis, A., Scherpereel, A., Paesmans, M., & Berghmans, T. (2006). A phase III randomised trial comparing sequential to standard chemotherapy in advanced non-small cell lung cancer (NSCLC). Journal of Clinical Oncology, 24(18), 367S. https://hdl.handle.net/2078.5/78777 (Original work published 2006)